Figures & data
Figure 1 Classification of hemodialysis patients into phosphate variability groups.
Abbreviations: cH, consistently high; cL, consistently low; cT, consistently target; HL, high-to-low; HT, high-to-target; TL, target-to-low.
![Figure 1 Classification of hemodialysis patients into phosphate variability groups.](/cms/asset/ac1e762b-b63c-44f6-a213-cd68068af473/dnrd_a_58037_f0001_b.jpg)
Table 1 Baseline demographic and clinical characteristics
Figure 2 Baseline characteristics by phosphate variability group.
Abbreviations: cH, consistently high; cL, consistently low; cT, consistently target; HL, high-to-low; HT, high-to-target; PTH, parathyroid hormone; SD, standard deviation; TL, target-to-low.
![Figure 2 Baseline characteristics by phosphate variability group.](/cms/asset/62424b6a-20a9-4cd7-98d9-e4410cba6d28/dnrd_a_58037_f0002_b.jpg)
Table 2 Baseline disease and medication characteristics
Figure 3 Trends in characteristics of the phosphate variability groups over time.
Abbreviations: BMI, body mass index; cH, consistently high; CI, confidence interval; cL, consistently low; cT, consistently target; eKt/V, equilibrated fractional clearance of body water of urea; HL, high-to-low; HT, high-to-target; TL, target-to-low.
![Figure 3 Trends in characteristics of the phosphate variability groups over time.](/cms/asset/9cb1a92a-6529-4474-ad85-5ca2372ea2ab/dnrd_a_58037_f0003_b.jpg)